Please refer the enclosed intimation letter.

August 13, 2026 To, To, National Stock Exchange of India Limited BSE Limited Exchange Plaza, C-1, Phiroze Jeejeebhoy Towers, Block G, Bandra Kurla Complex, Dalal Street, Mumbai- 400001 Bandra (E), Mumbai – 400051 Sub : Disclosure of Sale of 1,57,69,696 Equity Shares by Promoter – Docon Technologies Private Limited Ref : Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Dear Sir/Madam, We wish to inform you that Thyrocare Technologies Limited ("Company"/“Thyrocare”) has received disclosures from Docon Technologies Private Limited ("Docon"), a Promoter of the Company, informing the Company that Docon has sold 1,57,69,696 equity shares of the Company through market trades today, i.e., Thursday, August 13, 2026. The settlement of the transaction shall be carried out in accordance with the applicable laws and regulations. The shares sold represent approximately 9.90% of the total paid-up equity share capital of the Company. Following the aforesaid transaction, Docon continues to be a Promoter and holding company of Thyrocare. Consequently, the promoter shareholding in the Company has reduced from 60.92% to 51.02% of the total paid-up equity share capital. We request you to kindly take the same on record. Yours Faithfully, For Thyrocare Technologies Limited, Brijesh Kumar Company Secretary and Compliance Officer